Doxorubicin and paclitaxel carried by methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) is superior than traditional drug-delivery methods
文献类型:期刊论文
| 作者 | Song, Yipeng2; Wang, Jin2; Zhao, Ruifang3; Hu, Yili2; Zhu, Xiaoyang2; Wang, Yulan2,4; Tang, Huiru1,2; Nie, Guangjun3 |
| 刊名 | NANOMEDICINE
![]() |
| 出版日期 | 2018-04-01 |
| 卷号 | 13期号:8页码:913-928 |
| 关键词 | Anticancer Drugs Biomedical Applications Metabonomics Nuclear Magnetic Resonance Nmr Polymer Nanoparticles |
| DOI | 10.2217/nnm-2017-0363 |
| 文献子类 | Article |
| 英文摘要 | Aim: To evaluate the advantages of nanomaterial methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) (mPEG-PLGA) encapsulated doxorubicin (D/DOX) and paclitaxel (T/TAX; mPEG-PLGA-DT) over free form of DOX and TAX (DOX/TAX).Materia Is & methods: Metabonomics was conducted to characterize the systemic metabolic response of allograft breast cancer model mice to mPEG-PLGA-DT and DOX/TAX treatments. Results: Breast tumor growth induced metabolic reprogram in serum and multiple organs. DOX/TAX treatment could ameliorate the elevated energy and nucleotides demands in some organs while mPEG-PLGA-DT treatment showed outstanding therapeutic outcomes in restoring the metabolic phenotypes of serum and kidney from tumor-bearing mice to the healthy state. Conclusion: This investigation proved the biological advantages of mPEG-PLGA-DT over DOX/TAX in molecular level through the comparison between their metabolic responses in vivo. |
| WOS关键词 | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA ; ENHANCED ANTITUMOR EFFICACY ; PLGA-PEG NANOPARTICLES ; BREAST-CANCER ; ENDOMETRIAL CARCINOMA ; GLUTATHIONE DEPLETION ; ANTICANCER DRUG ; CERVICAL-CANCER ; OVARIAN-CANCER ; LUNG-CANCER |
| WOS研究方向 | Biotechnology & Applied Microbiology ; Science & Technology - Other Topics |
| 语种 | 英语 |
| WOS记录号 | WOS:000432932200008 |
| 资助机构 | National Natural Science Foundation of China(21675169 ; National Natural Science Foundation of China(21675169 ; Ministry of Science and Technology 973(2017YFC0906800 ; Ministry of Science and Technology 973(2017YFC0906800 ; 21375144 ; 21375144 ; 2012CB934004) ; 2012CB934004) ; 91439102 ; 91439102 ; 81590953) ; 81590953) ; National Natural Science Foundation of China(21675169 ; National Natural Science Foundation of China(21675169 ; Ministry of Science and Technology 973(2017YFC0906800 ; Ministry of Science and Technology 973(2017YFC0906800 ; 21375144 ; 21375144 ; 2012CB934004) ; 2012CB934004) ; 91439102 ; 91439102 ; 81590953) ; 81590953) |
| 源URL | [http://ir.wipm.ac.cn/handle/112942/11979] ![]() |
| 专题 | 武汉物理与数学研究所_磁共振应用研究部 |
| 作者单位 | 1.Fudan Univ, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Metabol & Syst Biol Lab,Sch Life Sci, Shanghai 200433, Peoples R China 2.Univ Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, CAS Key Lab Magnet Resonance Biol Syst,State Key, Wuhan 430071, Hubei, Peoples R China 3.Natl Ctr Nanosci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosaftey, Beijing 100190, Peoples R China 4.Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China |
| 推荐引用方式 GB/T 7714 | Song, Yipeng,Wang, Jin,Zhao, Ruifang,et al. Doxorubicin and paclitaxel carried by methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) is superior than traditional drug-delivery methods[J]. NANOMEDICINE,2018,13(8):913-928. |
| APA | Song, Yipeng.,Wang, Jin.,Zhao, Ruifang.,Hu, Yili.,Zhu, Xiaoyang.,...&Nie, Guangjun.(2018).Doxorubicin and paclitaxel carried by methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) is superior than traditional drug-delivery methods.NANOMEDICINE,13(8),913-928. |
| MLA | Song, Yipeng,et al."Doxorubicin and paclitaxel carried by methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) is superior than traditional drug-delivery methods".NANOMEDICINE 13.8(2018):913-928. |
入库方式: OAI收割
来源:武汉物理与数学研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

